Terms: = Breast cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Clinical Outcome
5 results:
1. Nuclear Factor Erythroid 2-Related Factor 2 in Regulating cancer Metabolism.
Smolková K; Mikó E; Kovács T; Leguina-Ruzzi A; Sipos A; Bai P
Antioxid Redox Signal; 2020 Nov; 33(13):966-997. PubMed ID: 31989830
[No Abstract] [Full Text] [Related]
2. The prognostic value of nrf2 in breast cancer patients: a systematic review with meta-analysis.
Almeida M; Soares M; Ramalhinho AC; Moutinho JF; Breitenfeld L; Pereira L
Breast Cancer Res Treat; 2020 Feb; 179(3):523-532. PubMed ID: 31745730
[TBL] [Abstract] [Full Text] [Related]
3. Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation.
Dong H; Wang W; Mo S; Liu Q; Chen X; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J; Hu J
J Cell Mol Med; 2018 Oct; 22(10):4935-4947. PubMed ID: 30063126
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (nrf2) expression in gastric cancer.
Kawasaki Y; Ishigami S; Arigami T; Uenosono Y; Yanagita S; Uchikado Y; Kita Y; Nishizono Y; Okumura H; Nakajo A; Kijima Y; Maemura K; Natsugoe S
BMC Cancer; 2015 Jan; 15():5. PubMed ID: 25588809
[TBL] [Abstract] [Full Text] [Related]
5. Mitochondria "fuel" breast cancer metabolism: fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells.
Sotgia F; Whitaker-Menezes D; Martinez-Outschoorn UE; Salem AF; Tsirigos A; Lamb R; Sneddon S; Hulit J; Howell A; Lisanti MP
Cell Cycle; 2012 Dec; 11(23):4390-401. PubMed ID: 23172368
[TBL] [Abstract] [Full Text] [Related]
